Indiana University (IU)

Indianapolis, Indiana 46202

1 studies enrolling now · 5 studies all time

What they study most

Advanced Solid Tumor, Chlamydia Trachomatis Infection, Colorectal Cancer, DM1, Dystrophy Myotonic, Fallopian Tube Cancer, Metastatic Solid Tumor, Myotonia, Myotonic Disorders, Myotonic Dystrophy, Myotonic Dystrophy 1, Myotonic Dystrophy Type 1

Studies at this site

• Global Open-Label Extension Study of Del-desiran for the Treatment of DM1 — Enrolling by invitation
• A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors — Running, not enrolling
• Global Study of Del-desiran for the Treatment of DM1 — Running, not enrolling
• Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7) — Stopped early
• NeuMoDx PrEDiCTiNG Study Evaluation Plan — Completed